Prevnar 13® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection 0.5 mL

Name: Pneumonia Vaccine
Brand: Prevnar 13®

PREVNAR 13, SYR 0.5ML (10/CT) 9WYETH

McKesson #

795986

Manufacturer #

00005197102

Brand

Prevnar 13®

Manufacturer

Pfizer (RSV Vaccines)

Country of Origin

Unknown

Alternate Manufacturer Number

1614650

Application

Pneumonia Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

28232

Generic Drug Name

Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free

NDC Number

00005197102

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

2.2 mcg - 4.4 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201615

User

Indicated for People 6 Weeks to 5 Years of Age and for People 50 Years of Age and Older

Volume

0.5 mL

In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
The tip cap and rubber plunger of the prefilled syringe do not contain latex
Store Refrigerated at 2° to 8°C (36° to 46°F)